Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 7
2019 11
2020 7
2021 11
2022 11
2023 8
2024 6
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
The novel function of bexarotene for neurological diseases.
Liu Y, Wang P, Jin G, Shi P, Zhao Y, Guo J, Yin Y, Shao Q, Li P, Yang P. Liu Y, et al. Ageing Res Rev. 2023 Sep;90:102021. doi: 10.1016/j.arr.2023.102021. Epub 2023 Jul 24. Ageing Res Rev. 2023. PMID: 37495118 Review.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan.
Matsumura N, Mandai M. Matsumura N, et al. Int J Clin Oncol. 2024 Sep;29(9):1207-1208. doi: 10.1007/s10147-024-02579-z. Int J Clin Oncol. 2024. PMID: 39007945 No abstract available.
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study.
Manaka K, Sato J, Hikima Y, Horikoshi H, Taguchi M, Morita A, Suga H, Boki H, Fujimura T, Hirai Y, Shimauchi T, Tateishi C, Kiyohara E, Muto I, Nakajima H, Abe R, Fujii K, Nishigori C, Nakano E, Yonekura K, Funakoshi T, Amano M, Miyagaki T, Yamashita R, Sugaya M, Hamada T, Nangaku M, Iiri T, Makita N. Manaka K, et al. Endocr J. 2024 Aug 8;71(8):777-787. doi: 10.1507/endocrj.EJ23-0699. Epub 2024 Jun 5. Endocr J. 2024. PMID: 38839346 Free article.
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas.
Izu-Belloso R, Gainza-Apraiz I, Ortiz-Romero P, Servitje-Bedate O, Fernández de Misa-Cabrera R, Peñate Y, Hernandez-Machin B, Estrach-Panella T, Llamas-Velasco M, Yanguas-Bayona JI, Morillo-Andujar M, Acebo-Mariñas E, Perez-Gala S, Armario-Hita JC, Sanchez-Sambucety P, Ortiz-Brugues A, Eguren-Michelena C, Bielsa-Marsol I, Lopez-Pestaña A, Blanes-Martinez M, Fernandez-Guarino M, Lopez-Lerma I. Izu-Belloso R, et al. Actas Dermosifiliogr. 2024 Jun;115(6):547-554. doi: 10.1016/j.ad.2023.12.007. Epub 2024 Feb 22. Actas Dermosifiliogr. 2024. PMID: 38395224 Free article. English, Spanish.
64 results